Business / Finance

RSS

Particle Sciences to expand sterile manufacturing for complex products and particulates

Particle Sciences, Inc (PSI), the leading CDMO for micro and nano-particulates is expanding its sterile and aseptic manufacturing capacity generally and specifically for nano-milled drug products.

9 Mar 2015

G-treeBNT to receive $7.28 million to expand international development of RGN-259/GBT-201

RegeneRx Biopharmaceuticals, Inc. has been notified that its joint venture partner and licensee, G-treeBNT Co. Ltd., will receive $7.28 million USD to expand international development of its product candidate, RGN-259 (designated GBT-201).

9 Mar 2015

Greystone expands with acquisition of Autumn Health Care's skilled nursing facilities in Ohio

Greystone Healthcare Management Corp. continues to grow its network of healthcare facilities, home health agencies and hospice care services in Florida and Ohio with the acquisition from Autumn Health Care of its 10 skilled nursing facilities, with a total of 614 beds, in the central Ohio area.

9 Mar 2015

EMD Serono executes amendment agreement with Opexa for development of Tcelna (imilecleucel-T)

EMD Serono, the biopharmaceutical division of Merck KGaA, Darmstadt, Germany, announced today the execution of an amendment to its agreement with Opexa Therapeutics, Inc. for the development and commercialization of its investigational compound Tcelna (imilecleucel-T).

9 Mar 2015

Carter Validus Mission Critical REIT II buys Heartland Rehabilitation Hospital property from Medistar

Medistar Corporation announced that it has sold the Heartland Rehabilitation Hospital property to Carter Validus Mission Critical REIT II, Inc. on February 17th 2015. The rehabilitation hospital is located in Overland Park, Kansas.

5 Mar 2015

Nova Medical Centers announces acquisition of Industrial Medicine

Occupational medicine company, Nova Medical Centers, is excited to announce the acquisition of Industrial Medicine, P.C. in Savannah, GA.

5 Mar 2015

European launch of the Proxima miniature in-line blood gas analyser at ISICEM 2015

Sphere Medical, innovator in critical care monitoring and diagnostics equipment, will launch its ground-breaking in-line patient dedicated arterial blood gas analyser in Germany, Netherlands and Belgium at ISICEM 2015.

5 Mar 2015

Mallinckrodt enters into definitive agreement to acquire Ikaria

Mallinckrodt plc, a leading global specialty biopharmaceutical company, and Ikaria, Inc. a privately-held critical care company, announced today that they have entered into a definitive agreement under which a subsidiary of Mallinckrodt will acquire Ikaria, Inc. from a Madison Dearborn-led investor group in a transaction valued at approximately $2.3 billion.

5 Mar 2015

ANI acquires approved ANDA for Flecainide Acetate tablets USP

ANI Pharmaceuticals, Inc. today announced that it has acquired the approved abbreviated new drug application ("ANDA") for Flecainide Acetate tablets USP 50mg, 100mg and 150mg, previously marketed by Teva Pharmaceuticals.

5 Mar 2015

Babies treated for CMV infection for six months have better developmental outcomes

Babies treated for symptomatic cytomegalovirus (CMV) infection for six months, instead of the standard six weeks, have better hearing and developmental outcomes, according to a new study from the University of Alabama at Birmingham.

5 Mar 2015

Surgical science wins ACG minnesota BOLD award

Surgical Science, leading developer of virtual reality surgical simulation training systems, was the recipient of the 2015 Small Corporate BOLD Award from the Association for Corporate Growth (ACG) Minnesota.

4 Mar 2015

IMRIS announces net loss of $6.8 million for fourth quarter 2014

IMRIS Inc. today reported financial results for the fourth quarter and full year ended December 31, 2014. All figures are reported in U.S. dollars. The Company's net loss in the 2014 fourth quarter was $6.8 million, or $0.13 per diluted share, on net revenues of $9.6 million.

4 Mar 2015

Mayo Clinic, Gentag partner to develop wearable biosensors for treating obesity, diabetes

Mayo Clinic and Gentag, Inc. have reached an agreement to develop the next generation of wearable biosensors designed to fight obesity and diabetes.

4 Mar 2015

PINN partners with Clinicient to strengthen clinical and business decisions

Clinicient Inc., a leader in outpatient rehabilitation business solutions, announced today that People's Injury Network Northwest, a preeminent industrial rehabilitation physical and occupational therapy provider in Washington state, has selected Clinicient's PracticeInsight cloud-based EMR and billing solutions.

4 Mar 2015

Halyard Health's net sales increase 2% to $439 million in fourth quarter 2014

Halyard Health, Inc. today reported year-end 2014 results and provided its 2015 outlook and related key planning assumptions.

4 Mar 2015

Lexicon updates drug development progress, reports 2014 financial results

Lexicon Pharmaceuticals, Inc., a biopharmaceutical company focused on developing breakthrough treatments for human disease, today updated its drug development progress and reported financial results for the three months and year ended December 31, 2014.

4 Mar 2015

Grifols, Alkahest sign definitive agreements

Grifols, a global healthcare company and leading producer of plasma therapies, and Alkahest, a Redwood City, California based, privately held biopharmaceutical company founded upon the pioneering work of Dr. Tony Wyss-Coray and other leading scientists at Stanford University, today announced that they have signed definitive agreements whereby Grifols will make a major equity investment in Alkahest, and the companies will work together to develop novel plasma-based products for the treatment of cognitive decline in aging and disorders of the central nervous system (CNS), including Alzheimer's.

4 Mar 2015

NHS savings plan led to cuts in some ‘ineffective’ treatments

The drive to reduce NHS spending led to a drop in some treatments considered ‘low-value’, according to new research.

4 Mar 2015

Apollo signs license option deal with Case Western to develop point-of-care blood analyzer

A blood test yields a wealth of information crucial to a person's health. What's needed is a device that is small and inexpensive, yet capable of quickly providing a thorough analysis using a very small sample.

4 Mar 2015

Regenicin receives final payment to conclude Asset Purchase Agreement with Amarantus

Regenicin, Inc. a biotechnology company specializing in the development of and commercialization of regenerative cell therapies to restore the health of damaged tissues and organs, announced today that it has received the final payment to conclude The Asset Purchase Agreement with Amarantus Bioscience Holdings, Inc.

3 Mar 2015

Business / Finance

Particle Sciences to expand sterile manufacturing for complex products and particulates

G-treeBNT to receive $7.28 million to expand international development of RGN-259/GBT-201

Greystone expands with acquisition of Autumn Health Care's skilled nursing facilities in Ohio

EMD Serono executes amendment agreement with Opexa for development of Tcelna (imilecleucel-T)

Carter Validus Mission Critical REIT II buys Heartland Rehabilitation Hospital property from Medistar

Nova Medical Centers announces acquisition of Industrial Medicine

European launch of the Proxima miniature in-line blood gas analyser at ISICEM 2015

Mallinckrodt enters into definitive agreement to acquire Ikaria

ANI acquires approved ANDA for Flecainide Acetate tablets USP

Babies treated for CMV infection for six months have better developmental outcomes

Surgical science wins ACG minnesota BOLD award

IMRIS announces net loss of $6.8 million for fourth quarter 2014

Mayo Clinic, Gentag partner to develop wearable biosensors for treating obesity, diabetes

PINN partners with Clinicient to strengthen clinical and business decisions

Halyard Health's net sales increase 2% to $439 million in fourth quarter 2014

Lexicon updates drug development progress, reports 2014 financial results

Grifols, Alkahest sign definitive agreements

NHS savings plan led to cuts in some ‘ineffective’ treatments

Apollo signs license option deal with Case Western to develop point-of-care blood analyzer

Regenicin receives final payment to conclude Asset Purchase Agreement with Amarantus

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Latest News